| Hans-Günter Meyer-Thompson | Substitution in Haft
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open-label, non-randomised trial of long-acting injectable buprenorphine treatment in Australian custodial settings.
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open-label, non-randomised trial of long-acting injectable buprenorphine treatment in Australian custodial settings.
White B, Little S, Haber PS, Roberts J, Nolan E, Lintzeris N, Dunlop AJ.
Drug Alcohol Rev. 2025 Feb;44(2):640-648. doi: 10.1111/dar.14005. Epub 2025 Feb 3. PMID: 39901317; PMCID: PMC11814349.